Microgreens: Emerging phytochemical powerhouses for chronic disease management

Microgreens are tender, edible seedlings harvested at the cotyledonary to early true-leaf stage (7-21 days after germination) and are increasingly recognized as nutrient-dense functional foods.Comparative studies indicate that microgreens may contain 4-40 times higher concentrations of certain vitamins and carotenoids than their mature counterparts, depending on species and growth conditions.For example, red cabbage microgreens have been reported to contain significantly elevated levels of vitamin C (up to 147 mg/100 g fresh weight) and total phenolics exceeding 1000 mg gallic acid equivalents/100 g fresh weight.Brassicaceae microgreens are particularly rich in glucosinolates, with sulforaphane precursors ranging between 2-5 fold higher than mature leave.The dense phytochemical composition, including phenolic acids, flavonoids, carotenoids (-carotene, lutein) and essential minerals (Fe, Zn, Mg), contributes to strong antioxidant activity, often demonstrating 20-50 per cent greater radical scavenging capacity in DPPH and FRAP assays compared to mature vegetables.Mechanistically, bioactive compounds in microgreens modulate oxidative stress and inflammatory pathways through NF-B suppression and Nrf2 activation, thereby reducing cellular damage associated with chronic diseases.Emerging in vitro and in vivo studies demonstrate improvements in lipid profiles (10-25% reduction in LDL oxidation) and significant inhibition of a-amylase and a-glucosidase enzymes (15-35%), suggesting potential benefits in diabetes and cardiovascular disease management.Despite promising biochemical and preclinical evidence, well-designed human clinical trials remain limited.Given their rapid growth cycle, minimal resource requirements and high bioactive compound density, microgreens represent a sustainable and scalable dietary strategy for chronic disease prevention and integrative healthcare.Further standardized clinical investigations are required to validate dosage, safety and long-term therapeutic efficacy.